TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank67
3Y CAGR+8.3%
5Y CAGR+34.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+8.3%/yr
Annual compound
5Y CAGR
+34.4%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $152.41M | -14.7% |
| 2024 | $178.69M | +34.0% |
| 2023 | $133.36M | +11.1% |
| 2022 | $120.03M | -25.6% |
| 2021 | $161.41M | +363.9% |
| 2020 | $34.79M | -16.7% |
| 2019 | $41.76M | - |